MTOR and acute myeloid leukemia: The LKB1/AMPK/mTOR axis functions in hematopoietic cancers, such as acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL); consequently, metformin represents a new perspective in hematological cancer therapy.